Technicals for Aurobindo Pharma Limited
The STOCHASTIC is showing a neutral stance, with no definitive indication of...
The STOCHASTIC is showing a neutral stance, with no definitive indication of...
Aurobindo Pharma Limited's forward EPS exceeding its trailing EPS reflects expectations of...
The list of all important regulatory filings for Aurobindo Pharma Limited which...
The article discusses how AI technologies are leveraging digital footprints to provide...
An analysis of why European banks continue to report strong profits despite...
A comprehensive analysis of the OECD's warning regarding the systemic risks posed...
Published | Title | Summary |
---|---|---|
2025-03-28 11:20:51 | Acquisition | Aurobindo Pharma Limited has informed the Exchange about Acquisition... |
2025-02-28 17:55:09 | Acquisition | Aurobindo Pharma Limited has informed the Exchange about Acquisition... |
2025-02-07 14:47:36 | Acquisition-XBRL | AUROBINDO PHARMA LIMITED has informed the Exchange regarding Acquisition... |
2025-02-07 14:45:47 | Acquisition-XBRL | AUROBINDO PHARMA LIMITED has informed the Exchange regarding Acquisition... |
2025-02-06 20:25:54 | Acquisition | Aurobindo Pharma Limited has informed the Exchange about Acquisition... |
2025-02-06 20:03:05 | Acquisition | Aurobindo Pharma Limited has informed the Exchange about Acquisition... |
2025-01-17 12:05:32 | Board Meeting Intimation | AUROBINDO PHARMA LIMITED has informed the Exchange about Board Meeting... |
2024-09-18 17:28:51 | Acquisition-XBRL | AUROBINDO PHARMA LIMITED has informed the Exchange regarding Acquisition... |
2024-09-18 15:27:06 | Acquisition | Aurobindo Pharma Limited has informed the Exchange about Acquisition... |
2024-08-26 13:34:44 | Buyback | Aurobindo Pharma Limited has informed the Exchange about Buyback... |
2024-07-31 10:15:15 | Board Meeting Intimation | AUROBINDO PHARMA LIMITED has informed the Exchange about Board Meeting... |
2024-05-02 14:32:31 | Acquisition | Aurobindo Pharma Limited has informed the Exchange about Acquisition... |
Lists of companies in NSE500 with the best and the worst technicals...
Lists of companies in NSE500 with the best and the worst fundamentals...
List of the latest important filings for NSE500....
Analysts are raising red flags about the $1.7 trillion private credit market,...
An analysis of the professions that are expected to remain resilient in...
An in-depth examination of the factors contributing to the U.S. dollar's multi-year...